You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
26 June 2020
France is establishing national production of paracetamol, the European Medicines Agency (EMA) is set to take another look at ranitidine, and GlaxoSmithKline (GSK) Consumer Healthcare has recalled some children’s medicines.
29 May 2020
Sanofi’s Consumer Healthcare business will have a new worldwide head from 1 September 2020.
28 April 2020
Sanofi's Consumer Healthcare business reported worldwide sales up by 4.2% at constant exchange rates in the first quarter of 2020. Paul Hudson, Sanofi's chief executive officer, said consumer stocking associated with the COVID-19 pandemic had contributed around six percentage points of growth.
28 April 2020
Sanofi Consumer Healthcare’s development plans for switching Cialis (tadalafil) and Tamiflu (oseltamivir) from prescription-to-OTC status in the US remain “on track”, according to Paul Hudson, Sanofi’s chief executive officer.
17 April 2020
Sanofi is joining forces with Luminostics to develop a self-testing solution for COVID-19 that uses smartphones. The two companies aim to have the OTC product ready “before the end of 2020”.
9 April 2020
Galenica has issued financial guidance in light of the COVID-19 pandemic, Adamed has launched Maxon Forte (sildenafil) in Poland, and Sanofi Consumer Healthcare is partnering with Plug and Play Japan.
3 March 2020
Sanofi Consumer Healthcare’s deal for exclusive OTC rights to Roche’s Tamiflu (oseltamivir) in the US has won the OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.
3 March 2020
Sanofi plans to create a European active pharmaceutical ingredients (API) supplier, Abbvie has provided an update on its planned takeover of Allergan, and Adcock Ingram has released financial results.
12 February 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 5.2% at constant exchange rates in the fourth quarter of 2019. The company said the fall was due to the voluntary recall of Zantac (ranitidine), non-core brand divestments, and product suspensions due to changing regulatory requi...
10 December 2019
Sanofi’s new chief executive officer Paul Hudson is restructuring the company into three “core” global business units and a “standalone” Consumer Healthcare operation.